Anti-mycobacterial immunity induced by a single injection of M. leprae Hsp65-encoding plasmid DNA in biodegradable microparticles

Immunology Letters

Volumn 90, Issue 2-3, 2003, Pages 81-85

  Johansen, Pål ^a,b,c   Raynaud, Catherine ^a   Yang, Min ^a   Colston, M Jo ^a   Tascon, Ricardo E ^a   Lowrie, Douglas B ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

DNA vaccine; Microspheres; Tuberculosis

Indexed keywords

HEAT SHOCK PROTEIN 65; MICROSPHERE; PLASMID DNA; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBODY TITER; ARTICLE; BACTERIAL IMMUNITY; BIODEGRADABILITY; CONTROLLED STUDY; FEMALE; MACROPHAGE; MOUSE; MOUSE STRAIN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT PLASMID; SPLEEN CELL; TUBERCULOSIS;

EID: 0345734379     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(03)00176-7     Document Type: Article

References (28)

1. Pachuk C.J., McCallus D.E., Weiner D.B., Satishchandran C. Curr. Opin. Mol. Ther. 2:2000;188-198.
2. Scheerlinck J.Y. Vaccine. 19:2001;2647-2656.
3. McKenzie B.S., Corbett A.J., Brady J.L., Dyer C.M., Strugnell R.A., Kent S.J., Kramer D.R., Boyle J.S., Lew A.M. Immunol. Res. 24:2001;225-244.
4. D.B. Lowrie, in: A. Robinson, M. Cranage, M. Hudson (Eds.), Vaccine Protocols, Humana, Totowa, 2003.
5. McCluskie M.J., Weeratna R.D. Curr. Drug Targets Infect. Disord. 1:2001;263-271.
6. Orson F.M., Song L., Gautam A., Densmore C.L., Bhogal B.S., Kinsey B.M. Gene Ther. 9:2002;463-471.
7. Gregoriadis G. Curr. Opin. Mol. Ther. 1:1999;39-42.
8. Pietzonka P., Walter E., Duda-Johner S., Langguth P., Merkle H.P. Eur. J. Pharm. Sci. 15:2002;39-47.
9. Vordermeier H.M., Coombes A.G., Jenkins P., McGee J.P., O'Hagan D.T., Davis S.S., Singh M. Vaccine. 13:1995;1576-1582.
10. Dhiman N., Khuller G.K. FEMS Immunol. Med. Microbiol. 21:1998;19-28.
11. Johansen P., Men Y., Merkle H.P., Gander B. Eur. J. Pharm. Biopharm. 50:2000;129-146.
12. Ignatius A.A., Claes L.E. Biomaterials. 17:1996;831-839.
13. Thomasin C., Corradin G., Men Y., Merkle H.P., Gander B. J. Control. Release. 41:1996;131-148.
14. Kundig T.M., Bachmann M.F., Ohashi P.S., Pircher H., Hengartner H., Zinkernagel R.M. Immunol. Rev. 150:1996;63-90.
15. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D., Lowrie D.B. Nat. Med. 2:1996;888-892.
16. Lowrie D.B., Tascon R.E., Bonato V.L., Lima V.M., Faccioli L.H., Stavropoulos E., Colston M.J., Hewinson R.G., Moelling K., Silva C.L. Nature. 400:1999;269-271.
17. Chapman B.S., Thayer R.M., Vincent K.A., Haigwood N.L. Nucleic Acids Res. 19:1991;3979-3986.
18. Johansen P., Men Y., Audran R., Corradin G., Merkle H.P., Gander B. Pharm. Res. 15:1998;1103-1110.
19. Meinel L., Illi O.E., Zapf J., Malfanti M., Peter Merkle H., Gander B. J. Control. Release. 70:2001;193-202.
20. Johansen P., Estevez F., Zurbriggen R., Merkle H.P., Gluck R., Corradin G., Gander B. Vaccine. 19:2000;1047-1054.
21. Walter E., Dreher D., Kok M., Thiele L., Kiama S.G., Gehr P., Merkle H.P. J. Control. Release. 76:2001;149-168.
22. Rhodes J. Immunol. Today. 17:1996;436-441.
23. Silva C.L., Lowrie D.B. Infect. Immun. 68:2000;3269-3274.
24. Walter E., Merkle H.P. J. Drug Target. 10:2002;11-21.
25. Denis-Mize K.S., Dupuis M., MacKichan M.L., Singh M., Doe B., O'Hagan D., Ulmer J.B., Donnelly J.J., McDonald D.M., Ott G. Gene Ther. 7:2000;2105-2112.
26. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. J. Exp. Med. 178:1993;2249-2254.
27. Walter E., Moelling K., Pavlovic J., Merkle H.P. J. Control. Release. 61:1999;361-374.
28. Johansen P., Merkle H.P., Gander B. Biochem. Biophys. Acta. 1425:1998;425-436.